{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:43:17Z","timestamp":1790026997850,"version":"4.0.1"},"reference-count":54,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2022,1,1]]},"DOI":"10.1001\/jamadermatol.2021.4704","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T11:07:34Z","timestamp":1637752054000},"page":"33","source":"Crossref","is-referenced-by-count":58,"title":["Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF)"],"prefix":"10.1001","volume":"158","author":[{"given":"Deonna M.","family":"Ackermann","sequence":"first","affiliation":[{"name":"School of Public Health, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mbathio","family":"Dieng","sequence":"additional","affiliation":[{"name":"National Health and Medical Research Council (NHMRC) Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie","family":"Medcalf","sequence":"additional","affiliation":[{"name":"School of Public Health, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa C.","family":"Jenkins","sequence":"additional","affiliation":[{"name":"School of Public Health, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathelijne H.","family":"van Kemenade","sequence":"additional","affiliation":[{"name":"School of Public Health, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Janda","sequence":"additional","affiliation":[{"name":"Centre for Health Services Research, The University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin M.","family":"Turner","sequence":"additional","affiliation":[{"name":"Biostatistics Centre, University of Otago, Dunedin, Otago, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Cust","sequence":"additional","affiliation":[{"name":"School of Public Health, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"The Daffodil Centre, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael L.","family":"Morton","sequence":"additional","affiliation":[{"name":"National Health and Medical Research Council (NHMRC) Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Les","family":"Irwig","sequence":"additional","affiliation":[{"name":"School of Public Health, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Guitera","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Royal Prince Alfred Hospital, Sydney, New South Wales, Australia"},{"name":"Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Peter","family":"Soyer","sequence":"additional","affiliation":[{"name":"Dermatology Research Centre, The University of Queensland Diamantina Institute, The University of Queensland, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Mar","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolyn K.","family":"Hersch","sequence":"additional","affiliation":[{"name":"School of Public Health, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Low","sequence":"additional","affiliation":[{"name":"Cancer Voices New South Wales, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Low","sequence":"additional","affiliation":[{"name":"Cancer Voices New South Wales, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn P. M.","family":"Saw","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Scolyer","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Royal Prince Alfred Hospital, Sydney, New South Wales, Australia"},{"name":"Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"New South Wales Health Pathology, Sydney, New South Wales, Australia"},{"name":"Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Drabarek","sequence":"additional","affiliation":[{"name":"School of Public Health, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Espinoza","sequence":"additional","affiliation":[{"name":"National Health and Medical Research Council (NHMRC) Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Azzi","sequence":"additional","affiliation":[{"name":"Newcastle Skin Check, Newcastle, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alister M.","family":"Lilleyman","sequence":"additional","affiliation":[{"name":"Newcastle Skin Check, Newcastle, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia K.","family":"Smit","sequence":"additional","affiliation":[{"name":"School of Public Health, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"The Daffodil Centre, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Murchie","sequence":"additional","affiliation":[{"name":"Academic Primary Care Research Group, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Royal Prince Alfred Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy J. L.","family":"Bell","sequence":"additional","affiliation":[{"name":"School of Public Health, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"doi210061r1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/bjd.15510","article-title":"The global burden of melanoma: results from the Global Burden of Disease Study 2015.","volume":"177","author":"Karimkhani","year":"2017","journal-title":"Br J Dermatol"},{"issue":"2","key":"doi210061r2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/bjd.15688","article-title":"Beyond country-specific incidence and mortality: the global burden of melanoma.","volume":"178","author":"Bell","year":"2018","journal-title":"Br J Dermatol"},{"key":"doi210061r5","doi-asserted-by":"publisher","first-page":"v126","DOI":"10.1093\/annonc\/mdv297","article-title":"Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.","volume":"26","author":"Dummer","year":"2015","journal-title":"Ann Oncol"},{"issue":"3","key":"doi210061r6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00520-008-0444-y","article-title":"Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence.","volume":"17","author":"Simard","year":"2009","journal-title":"Support Care Cancer"},{"issue":"11","key":"doi210061r7","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1002\/pon.4366","article-title":"Fear of new or recurrent melanoma after treatment for localised melanoma.","volume":"26","author":"Bell","year":"2017","journal-title":"Psychooncology"},{"issue":"4","key":"doi210061r8","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/pon.3060","article-title":"Psychosocial aspects of post-treatment follow-up for stage I\/II melanoma: a systematic review of the literature.","volume":"22","author":"Rychetnik","year":"2013","journal-title":"Psychooncology"},{"key":"doi210061r9","doi-asserted-by":"publisher","first-page":"S1164","DOI":"10.1245\/s10434-015-4589-x","article-title":"How often do patients with localized melanoma attend follow-up at a specialist center?","volume":"22","author":"Memari","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"doi210061r10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1001\/jamadermatol.2014.1952","article-title":"Specialized surveillance for individuals at high risk for melanoma: a cost analysis of a high-risk clinic.","volume":"151","author":"Watts","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"4","key":"doi210061r11","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1001\/jamadermatol.2013.9313","article-title":"Clinical skin examination outcomes after a video-based behavioral intervention: analysis from a randomized clinical trial.","volume":"150","author":"Janda","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"6","key":"doi210061r12","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1245\/s10434-007-9347-2","article-title":"Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines.","volume":"14","author":"Francken","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"doi210061r13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamadermatol.2018.0021","article-title":"Patient preferences for follow-up after recent excision of a localized melanoma.","volume":"154","author":"Lim","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"12","key":"doi210061r14","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1586\/14737140.2013.856272","article-title":"Melanoma patient self-detection: a review of efficacy of the skin self-examination and patient-directed educational efforts.","volume":"13","author":"Yagerman","year":"2013","journal-title":"Expert Rev Anticancer Ther"},{"key":"doi210061r15","doi-asserted-by":"publisher","DOI":"10.1177\/2055207619828225","article-title":"Evaluating healthcare practitioners\u2019 views on store-and-forward teledermoscopy services for the diagnosis of skin cancer.","volume":"5","author":"Janda","year":"2019","journal-title":"Digit Health"},{"issue":"1","key":"doi210061r16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/ddg.13729_g","article-title":"Survey on the status of teledermatology in Austria. JDDG","volume":"17","author":"Eber","year":"2019","journal-title":"J Deutschen Dermatol Gesellschaft."},{"issue":"4","key":"doi210061r17","doi-asserted-by":"publisher","DOI":"10.1111\/dth.v33.4","article-title":"Will teledermatology be the silver lining during and after COVID-19?","volume":"33","author":"Sharma","year":"2020","journal-title":"Dermatol Ther"},{"issue":"1","key":"doi210061r19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40814-019-0423-8","article-title":"A guide to the reporting of protocols of pilot and feasibility trials.","volume":"5","author":"Thabane","year":"2019","journal-title":"Pilot Feasibility Stud"},{"key":"doi210061r20","doi-asserted-by":"publisher","first-page":"i5239","DOI":"10.1136\/bmj.i5239","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials.","volume":"355","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"issue":"2","key":"doi210061r23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"doi210061r24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners.","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"8","key":"doi210061r25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-007993","article-title":"Total skin self-examination at home for people treated for cutaneous melanoma: development and pilot of a digital intervention.","volume":"5","author":"Murchie","year":"2015","journal-title":"BMJ Open"},{"issue":"1","key":"doi210061r26","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s13063-019-3453-x","article-title":"Achieving Self-Directed Integrated Cancer Aftercare (ASICA) in melanoma: protocol for a randomised patient-focused pilot trial of delivering the ASICA intervention as a means to earlier detection of recurrent and second primary melanoma.","volume":"20","author":"Murchie","year":"2019","journal-title":"Trials"},{"issue":"8","key":"doi210061r27","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","article-title":"Two-sided confidence intervals for the single proportion: comparison of seven methods.","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"issue":"7321","key":"doi210061r29","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/bmj.323.7321.1123","article-title":"Statistics notes: analysing controlled trials with baseline and follow-up measurements.","volume":"323","author":"Vickers","year":"2001","journal-title":"BMJ"},{"issue":"19","key":"doi210061r31","doi-asserted-by":"crossref","first-page":"7301","DOI":"10.1002\/cam4.3299","article-title":"Remote skin self-examination training of melanoma survivors and their skin check partners: a randomized trial and comparison with in-person training.","volume":"9","author":"Robinson","year":"2020","journal-title":"Cancer Med"},{"issue":"9","key":"doi210061r32","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamadermatol.2016.1985","article-title":"Early detection of new melanomas by patients with melanoma and their partners using a structured skin self-examination skills training intervention: a randomized clinical trial.","volume":"152","author":"Robinson","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"3","key":"doi210061r33","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/S2589-7500(20)30001-7","article-title":"Accuracy of mobile digital teledermoscopy for skin self-examinations in adults at high risk of skin cancer: an open-label, randomised controlled trial.","volume":"2","author":"Janda","year":"2020","journal-title":"Lancet Digit Health"},{"issue":"5","key":"doi210061r34","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1245\/s10434-019-07825-7","article-title":"The MelFo study: a multicenter, prospective, randomized clinical trial on the effects of a reduced stage-adjusted follow-up schedule on cutaneous melanoma IB\u2013IIC patients\u2014results after three years.","volume":"27","author":"Deckers","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"doi210061r35","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1245\/s10434-020-08758-2","article-title":"The MelFo study UK: effects of a reduced-frequency, stage-adjusted follow-up schedule for cutaneous melanoma 1B to 2C patients after 3-years.","volume":"27","author":"Moncrieff","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"doi210061r36","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jamadermatol.2019.0434","article-title":"Patients\u2019 views about skin self-examination after treatment for localized melanoma.","volume":"155","author":"Dieng","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"1","key":"doi210061r37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archderm.143.1.37","article-title":"Efficacy of a partner assistance intervention designed to increase skin self-examination performance.","volume":"143","author":"Robinson","year":"2007","journal-title":"Arch Dermatol"},{"issue":"1","key":"doi210061r38","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1111\/ajd.12877","article-title":"Remote partner assisted skin self-examination skills training of melanoma survivors and their partners.","volume":"60","author":"Robinson","year":"2019","journal-title":"Australas J Dermatol"},{"issue":"1","key":"doi210061r39","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s13063-021-05231-7","article-title":"Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? a protocol for the MEL-SELF randomised controlled trial.","volume":"22","author":"Ackermann","year":"2021","journal-title":"Trials"},{"issue":"1","key":"doi210061r40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1056\/NEJMsb2019760","article-title":"The rapid rise in cutaneous melanoma diagnoses.","volume":"384","author":"Welch","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"doi210061r41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5694\/mja2.50455","article-title":"Estimating the magnitude of cancer overdiagnosis in Australia.","volume":"212","author":"Glasziou","year":"2020","journal-title":"Med J Aust"},{"issue":"2","key":"doi210061r42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/CEJ.0000000000000056","article-title":"Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review.","volume":"24","author":"Gordon","year":"2015","journal-title":"Eur J Cancer Prev"},{"issue":"6","key":"doi210061r43","article-title":"Screening for reducing morbidity and mortality in malignant melanoma.","volume":"6","author":"Johansson","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"doi210061r44","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jama.2016.8465","article-title":"Screening for skin cancer: US Preventive Services Task Force Recommendation Statement.","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"issue":"7","key":"doi210061r45","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/jdv.17189","article-title":"Estimating the potential impact of interventions to reduce over-calling and under-calling of melanoma.","volume":"35","author":"Gibson","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"doi210061r46","doi-asserted-by":"crossref","first-page":"g7773","DOI":"10.1136\/bmj.g7773","article-title":"Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods.","volume":"350","author":"Carter","year":"2015","journal-title":"BMJ"},{"issue":"2","key":"doi210061r47","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/aje\/kwv342","article-title":"Conditions for valid empirical estimates of cancer overdiagnosis in randomized trials and population studies.","volume":"184","author":"Gulati","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"12","key":"doi210061r48","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S1470-2045(07)70380-7","article-title":"Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review.","volume":"8","author":"Biesheuvel","year":"2007","journal-title":"Lancet Oncol"},{"issue":"1","key":"doi210061r49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5694\/mja2.12033","article-title":"Methods of melanoma detection and of skin monitoring for individuals at high risk of melanoma: new Australian clinical practice.","volume":"210","author":"Adler","year":"2019","journal-title":"Med J Aust"},{"issue":"4","key":"doi210061r50","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/archderm.144.4.502","article-title":"Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma.","volume":"144","author":"Altamura","year":"2008","journal-title":"Arch Dermatol"},{"issue":"12","key":"doi210061r51","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/jamadermatol.2019.3064","article-title":"A state-of-the-art review highlighting medical overuse in dermatology, 2017-2018: a systematic review.","volume":"155","author":"Pournamdari","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"10090","key":"doi210061r52","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(16)32573-9","article-title":"Addressing overuse and underuse around the world.","volume":"390","author":"Saini","year":"2017","journal-title":"Lancet"},{"issue":"18","key":"doi210061r53","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1200\/JCO.2009.26.2063","article-title":"Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines.","volume":"28","author":"Romano","year":"2010","journal-title":"J Clin Oncol"},{"issue":"11","key":"doi210061r54","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1038\/jid.2015.326","article-title":"Melanoma incidence and lethality is increased following solid organ transplantation.","volume":"135","author":"Whiteman","year":"2015","journal-title":"J Invest Dermatol"},{"key":"doi210061r21","volume-title":"Your Guide to Early Melanoma","author":"Melanoma Institute of Australia","year":"2021","edition":"3rd ed"},{"key":"doi210061r22","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.","volume-title":"CA Cancer J Clin","author":"Gershenwald","year":"2017"},{"key":"doi210061r28","volume-title":"Manual for the Depression Anxiety Stress Scales","author":"Lovibond","year":"1995","edition":"2nd ed"},{"key":"doi210061r3","unstructured":"Australian Institute of Health and Welfare. Cancer in Australia, 2019. Accessed January 14, 2021. https:\/\/www.aihw.gov.au\/reports\/cancer\/cancer-in-australia-2019\/summary?"},{"key":"doi210061r4","unstructured":"Barbour? A, Guminski? A, Liu? W, Menzies? S, Morton? R. What is the ideal setting, duration and frequency of follow-up for melanoma patients? Clinical practice guidelines for the diagnosis and management of melanoma. 2019. Accessed January 14, 2021. https:\/\/wiki.cancer.org.au\/australia\/Clinical_question:What_is_the_ideal_setting,_duration_and_frequency_of_follow-up_for_melanoma_patients%3F"},{"key":"doi210061r18","unstructured":"Australian Bureau of Statistics. Census of population and housing: reflecting Australia\u2014stories from the census, 2016. Accessed February 4, 2021. https:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/Lookup\/2071.0main+features1132016"},{"key":"doi210061r30","unstructured":"Australian Bureau of Statistics. Remoteness structure, July 2016. Accessed October 20, 2020. https:\/\/www.abs.gov.au\/AUSSTATS\/abs@.nsf\/DetailsPage\/1270.0.55.005July%202016?OpenDocument?"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2786335\/jamadermatology_ackermann_2021_oi_210061_1651007182.56641.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T19:12:36Z","timestamp":1726168356000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2786335"}},"subtitle":["A Pilot Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2021.4704","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,1]]}}}